SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462 | +15.2% | 3,814 | +9.0% | 0.04% | +9.4% |
| Q2 2023 | $401 | +8.4% | 3,499 | +30.4% | 0.03% | +18.5% |
| Q1 2023 | $370 | -20.1% | 2,684 | -24.9% | 0.03% | -28.9% |
| Q4 2022 | $463 | -99.9% | 3,573 | -11.2% | 0.04% | -7.3% |
| Q3 2022 | $445,000 | -6.3% | 4,022 | -36.5% | 0.04% | -4.7% |
| Q2 2022 | $475,000 | +76.6% | 6,333 | +83.8% | 0.04% | +377.8% |
| Q1 2022 | $269,000 | – | 3,446 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |